Weiss Ratings Reiterates Sell (D-) Rating for Cardlytics (NASDAQ:CDLX)

by · The Markets Daily

Cardlytics (NASDAQ:CDLX – Get Free Report)‘s stock had its “sell (d-)” rating restated by equities research analysts at Weiss Ratings in a report released on Thursday,Weiss Ratings reports.

Separately, Evercore ISI reduced their target price on Cardlytics from $3.00 to $2.00 and set an “in-line” rating for the company in a report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $2.25.

View Our Latest Research Report on Cardlytics

Cardlytics Price Performance

Shares of NASDAQ CDLX opened at $1.94 on Thursday. Cardlytics has a 1-year low of $0.85 and a 1-year high of $5.25. The company has a debt-to-equity ratio of 2.87, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a fifty day moving average price of $1.80 and a 200 day moving average price of $1.77. The company has a market cap of $103.29 million, a PE ratio of -0.53 and a beta of 1.45.

Insider Buying and Selling

In other Cardlytics news, CEO Amit Gupta sold 68,685 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $1.12, for a total value of $76,927.20. Following the completion of the sale, the chief executive officer owned 491,759 shares of the company’s stock, valued at approximately $550,770.08. This trade represents a 12.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold a total of 159,335 shares of company stock valued at $204,204 over the last three months. 4.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Cardlytics during the 3rd quarter worth $26,000. Catalyst Funds Management Pty Ltd acquired a new position in shares of Cardlytics during the 2nd quarter worth $32,000. Post Resch Tallon Group Inc. raised its stake in shares of Cardlytics by 100.0% during the 2nd quarter. Post Resch Tallon Group Inc. now owns 20,000 shares of the company’s stock worth $33,000 after buying an additional 10,000 shares during the last quarter. Sand Hill Global Advisors LLC acquired a new position in shares of Cardlytics during the 2nd quarter worth $35,000. Finally, Jump Financial LLC acquired a new position in shares of Cardlytics during the 1st quarter worth $41,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories